N/A
N=20
EGM Analysis in Idiopathic Outflow Tract Ventricular Arrhythmia
Ventricular Outflow Tract Tachycardia
Bottom Line
View on ClinicalTrials.gov: NCT02722577 ↗Enrolled (actual)
20
Serious AEs
0.0%
Results posted
Jul 2019
Primary outcome: Primary: Percent of Ablation Targets With Termination of the Clinical Ventricular Arrhythmia After RF Energy Delivery — 20 Participants
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- Radio-frequency Ablation (Procedure)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Abbott Medical Devices
- Primary completion
- May 2017
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Percent of Ablation Targets With Termination of the Clinical Ventricular Arrhythmia After RF Energy Delivery |
20 | — |
Summary
Investigate the value of unipolar and bipolar electrograms (EGM) for predicting the successful ablation site for idiopathic outflow tract ventricular arrhythmia (OTVA).
Eligibility Criteria
Inclusion Criteria
- Patients scheduled to undergo ablation for idiopathic OTVA
- Have the ability to provide informed consent for study participation.
Exclusion Criteria
- Be currently participating in any other investigational study
- Be less than 18 years of age
- Be pregnant
- Has any other conditions that are not suitable for catheter ablation (including but are not limited to active whole-body infection or sepsis, coagulation or hemorrhage disorder history)
Data sourced from ClinicalTrials.gov (NCT02722577). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.